Evidence map›Paper›PMID 27366951›Full record

ArticleOncotarget2016

Multifunctional near-infrared light-triggered biodegradable micelles for chemo- and photo-thermal combination therapy.

Jie Cao, Dan Chen, Shanshan Huang, Dawei Deng, Liping Tang, Yueqing Gu

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Light-responsive biomaterials for ocular drug delivery.Drug delivery and translational research · 2023
    Review
  2. Review
  3. Article
  4. Article
  5. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.Frontiers in bioengineering and biotechnology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie CaoDepartment of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, China.
Dan ChenDepartment of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, China.
Shanshan HuangDepartment of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, China.
Dawei DengDepartment of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, China.
Liping TangDepartment of Bioengineering, University of Texas at Arlington, Arlington, Texas, USA.
Yueqing GuDepartment of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Engineering, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A combination of chemo- and photo-thermal therapy (PTT) has provided a promising efficient approach for cancer therapy. To achieve the superior synergistic chemotherapeutic effect with PTT, the development of a simple theranostic nanoplatform that can provide both cancer imaging and a spatial-temporal synchronism of both therapeutic approaches are highly desired. Our previous study has demonstrated that near-infrared (NIR) light-triggered biodegradable chitosan-based amphiphilic block copolymer micelles (SNSC) containing light-sensitive 2-nitrobenzyl alcohol and NIR dye cypate on the hydrophobic block could be used for fast light-triggered drug release. In this study, we conjugated the SNSC micelles with tumor targeting ligand c(RGDyK) and also encapsulated antitumor drug Paclitaxel (PTX). The results show that c(RGDyK)-modified micelles could enhance the targeting and residence time in tumor site, as well as be capable performing high temperature response for PTT on cancer cells and two-photon photolysis for fast release of anticancer drugs under NIR irradiation. In vitro release profiles show a significant controlled release effort that the release concentration of PTX from micelles was significantly increased with the exposure of NIR light. In vitro and in vivo antitumor studies demonstrate that, compared with chemo or PTT treatment alone, the combined treatment with the local exposure of NIR light exhibited significantly enhanced anti-tumor efficiency. These findings indicate that this system exhibited great potential in tumor-targeting imaging and synchronous chemo- and photo-thermal therapy.

Indexed as

Infrared RaysAnimalsAntineoplastic Agents, PhytogenicBenzyl AlcoholsBreast NeoplasmsChitosanDelayed-Action PreparationsDose-Response Relationship, DrugDrug CompoundingDrug StabilityFemaleFluorescent DyesHumansIndolesIntegrin alphaVbeta3MCF-7 Cells2-nitrobenzyl alcoholAntineoplastic Agents, PhytogenicBenzyl AlcoholsChitosancyclo(Arg-Gly-Asp-Tyr-Lys)CypateDelayed-Action PreparationsFluorescent DyesIndolesIntegrin alphaVbeta3MicellesPaclitaxelPeptides, CyclicPropionateschemotherapynear-infrared light-triggered nanomicellespaclitaxelphoto-thermal therapytumor targeting

Identifiers

PMID27366951
PMCPMC5347683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.